Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

OpenJDK is now able to build and run on iOS (and Android) as a native binary, opening the way to run unmodified Java code on ...

Practical enterprise implementation of AI requires not just the technology itself, but also strategic readiness in data, ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...